Literature DB >> 25765927

Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke.

Konstantinos Tziomalos1, Vasilios Giampatzis, Stella D Bouziana, Marianna Spanou, Maria Papadopoulou, Pavlina Kazantzidou, Stavroula Kostaki, Antonios Kouparanis, Christos Savopoulos, Apostolos I Hatzitolios.   

Abstract

It is unclear whether antihypertensive treatment before stroke affects acute ischemic stroke severity and outcome. To evaluate this association, the authors studied 482 consecutive patients (age 78.8±6.7 years) admitted with acute ischemic stroke. Stroke severity was assessed at admission with the National Institutes of Health Stroke Scale (NIHSS). The outcome was assessed with rates of adverse outcome (modified Rankin scale at discharge ≥2). Independent predictors of severe stroke (NIHSS ≥16) were female sex and atrial fibrillation. Treatment with diuretics before stroke was associated with nonsevere stroke. At discharge, patients with adverse outcome were less likely to be treated before stroke with β-blockers or with diuretics. Independent predictors of adverse outcome were older age, higher NIHSS at admission, and history of ischemic stroke. Treatment with diuretics before stroke appears to be associated with less severe neurologic deficit in patients with acute ischemic stroke.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25765927      PMCID: PMC8031997          DOI: 10.1111/jch.12498

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

1.  Effects of 24-hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke.

Authors:  Yasuhiro Tomii; Kazunori Toyoda; Rieko Suzuki; Masaki Naganuma; Jun Fujinami; Chiaki Yokota; Kazuo Minematsu
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

2.  The effect of valsartan versus non-RAAS treatment on autoregulation of cerebral blood flow.

Authors:  Daniel Périard; Marie-Antoinette Rey; Damien Casagrande; Jean-Marc Vesin; Emmanuel Carrera; Daniel Hayoz
Journal:  Cerebrovasc Dis       Date:  2012-07-14       Impact factor: 2.762

3.  Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.

Authors:  F Dalmay; H Mazouz; J Allard; F Pesteil; J M Achard; A Fournier
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-06       Impact factor: 1.636

4.  Pre-treatment with candesartan protects from cerebral ischaemia.

Authors:  T Ito; Y Nishimura; J Saavedra
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-09       Impact factor: 1.636

5.  Protective effects of beta-blockers in cerebrovascular disease.

Authors:  Somchai Laowattana; Stephen M Oppenheimer
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

6.  Angiotensin AT2 receptor stimulation increases survival in gerbils with abrupt unilateral carotid ligation.

Authors:  L A Fernandez; V J Caride; C Strömberg; L Näveri; J D Wicke
Journal:  J Cardiovasc Pharmacol       Date:  1994-12       Impact factor: 3.105

7.  Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

Authors:  Michael Böhm; Daniel Cotton; Lydia Foster; Florian Custodis; Ulrich Laufs; Ralph Sacco; Philip M W Bath; Salim Yusuf; Hans-Christoph Diener
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983

8.  Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.

Authors:  Takeshi Ito; Haruki Yamakawa; Claudia Bregonzio; José A Terrón; Alicia Falcón-Neri; Juan M Saavedra
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

9.  Primary stroke prevention and hypertension treatment: which is the first-line strategy?

Authors:  Roberta Ravenni; Joe F Jabre; Edoardo Casiglia; Alberto Mazza
Journal:  Neurol Int       Date:  2011-09-29

10.  Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study.

Authors:  Kimmo Herttua; Adam G Tabák; Pekka Martikainen; Jussi Vahtera; Mika Kivimäki
Journal:  Eur Heart J       Date:  2013-07-16       Impact factor: 29.983

View more
  5 in total

1.  Pre admission treatment with Beta-blockers in hypertensive patients with acute stroke and 3-month outcome-Data from a national stroke registry.

Authors:  Yoav Eizenberg; Ehud Grossman; David Tanne; Silvia Koton
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

2.  Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?

Authors:  Wen Yea Hwong; Michiel L Bots; Sharmini Selvarajah; Zariah Abdul Aziz; Norsima Nazifah Sidek; Wilko Spiering; L Jaap Kappelle; Ilonca Vaartjes
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

3.  Association of Nonsteroidal Anti-inflammatory Drug Use With Stroke Among Dialysis Patients.

Authors:  Chih-Cheng Hsu; Yu-Kang Chang; Yueh-Han Hsu; Yu-Ru Lo; Jia-Sin Liu; Chao A Hsiung; Hui-Ju Tsai
Journal:  Kidney Int Rep       Date:  2017-01-17

Review 4.  Effect of Beta-Blockers on Stroke Outcome: A Meta-Analysis.

Authors:  Hajnal Zsuzsanna Balla; Yang Cao; Jakob O Ström
Journal:  Clin Epidemiol       Date:  2021-03-16       Impact factor: 4.790

5.  Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke.

Authors:  Konstantinos Tziomalos; Vasilios Giampatzis; Stella D Bouziana; Marianna Spanou; Maria Papadopoulou; Pavlina Kazantzidou; Stavroula Kostaki; Antonios Kouparanis; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-13       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.